{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T15:39:24Z","timestamp":1776008364286,"version":"3.50.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>Effective treatment options for surfactant therapy in acute respiratory distress syndrome and coronavirus disease 2019 have not been established. To conduct preclinical studies in vitro and in vivo to evaluate efficiency, particle size, dosing, safety, and efficacy of inhaled surfactant using a breath-synchronized, nebulized delivery system in an established acute respiratory distress syndrome model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Preclinical study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Research laboratory.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Subjects:<\/jats:title>\n            <jats:p>Anesthetized pigs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>In vitro analysis included particle size distribution and inhaled dose during simulated ventilation using a novel breath-synchronized nebulizer. Physiologic effects of inhaled aerosolized surfactant (treatment) were compared with aerosolized normal saline (control) in an adult porcine model (weight of 34.3 \u00b1 0.6\u2009kg) of severe acute respiratory distress syndrome (Pa<jats:sc>o<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub>\/F<jats:sc>io<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> &lt;100) with lung lavages and ventilator-induced lung injury during invasive ventilation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Mass median aerosol diameter was 2.8 \u00b5m. In vitro dose delivered distal to the endotracheal tube during mechanical ventilation was 85% \u00b1 5%. Nebulizers were functional up to 20 doses of 108\u2009mg of surfactant. Surfactant-treated animals (<jats:italic toggle=\"yes\">n<\/jats:italic> = 4) exhibited rapid improvement in oxygenation with nearly full recovery of Pa<jats:sc>o<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub>\/F<jats:sc>io<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> (~300) and end-expiratory lung volumes with nominal dose less than 30\u2009mg\/kg of surfactant, whereas control subjects (<jats:italic toggle=\"yes\">n<\/jats:italic> = 3) maintained Pa<jats:sc>o<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub>\/F<jats:sc>io<\/jats:sc>\n                                 <jats:sub>2<\/jats:sub> less than 100 over 4.5 hours with reduced end-expiratory lung volume. There was notably greater surfactant phospholipid content and lower indicators of lung inflammation and pathologic lung injury in surfactant-treated pigs than controls. There were no peridosing complications associated with nebulized surfactant, but surfactant-treated animals had progressively higher airway resistance post treatment than controls with no differences in ventilation effects between the two groups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Breath-synchronized, nebulized bovine surfactant appears to be a safe and feasible treatment option for use in coronavirus disease 2019 and other severe forms of acute respiratory distress syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cce.0000000000000338","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T20:35:28Z","timestamp":1614371728000},"page":"e0338","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Breath-Synchronized Nebulized Surfactant in a Porcine Model of Acute Respiratory Distress Syndrome"],"prefix":"10.1097","volume":"3","author":[{"given":"Robert M.","family":"DiBlasi","sequence":"first","affiliation":[{"name":"Department of Respiratory Care Therapy, Seattle Children\u2019s Hospital and Regional Medical Center, Seattle, WA."},{"name":"Center for Integrative Brain Research, Seattle Children\u2019s Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kajimoto","sequence":"additional","affiliation":[{"name":"Center for Integrative Brain Research, Seattle Children\u2019s Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Poli","sequence":"additional","affiliation":[{"name":"Center for Integrative Brain Research, Seattle Children\u2019s Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Deutsch","sequence":"additional","affiliation":[{"name":"Department of Pathology, Seattle Children\u2019s Hospital and Regional Medical Center, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juergen","family":"Pfeiffer","sequence":"additional","affiliation":[{"name":"Scientific Research Partners, Moss Beach, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"Department of Respiratory Care Therapy, Seattle Children\u2019s Hospital and Regional Medical Center, Seattle, WA."},{"name":"Center for Integrative Brain Research, Seattle Children\u2019s Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Crotwell","sequence":"additional","affiliation":[{"name":"Department of Respiratory Care Therapy, Seattle Children\u2019s Hospital and Regional Medical Center, Seattle, WA."},{"name":"Center for Integrative Brain Research, Seattle Children\u2019s Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Malone","sequence":"additional","affiliation":[{"name":"Department of Respiratory Care Therapy, Seattle Children\u2019s Hospital and Regional Medical Center, Seattle, WA."},{"name":"Center for Integrative Brain Research, Seattle Children\u2019s Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B.","family":"Fink","sequence":"additional","affiliation":[{"name":"Aerogen Pharma Corporation, San Mateo, CA."},{"name":"Division of Respiratory Care, Department of Cardiopulmonary Sciences, Rush University Medical Center, Chicago, IL."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coral","family":"Ringer","sequence":"additional","affiliation":[{"name":"Department of Respiratory Care Therapy, Seattle Children\u2019s Hospital and Regional Medical Center, Seattle, WA."},{"name":"Clinical Effectiveness and System Support Services, Seattle Children\u2019s Hospital and Regional Medical Center, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Uthamanthil","sequence":"additional","affiliation":[{"name":"Center for Clinical and Translational Research, Seattle Children\u2019s Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolena","family":"Ledee","sequence":"additional","affiliation":[{"name":"Center for Integrative Brain Research, Seattle Children\u2019s Research Institute, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Portman","sequence":"additional","affiliation":[{"name":"Center for Integrative Brain Research, Seattle Children\u2019s Research Institute, Seattle, WA."},{"name":"Division of cardiology, Department of Pediatrics, University of Washington, Seattle, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,2,15]]},"reference":[{"key":"R1-20240807","first-page":"2526","article-title":"Acute respiratory distress syndrome: The Berlin definition.","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"R2-20240807","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1164\/rccm.202005-2046OC","article-title":"Compliance phenotypes in early acute respiratory distress syndrome before the COVID-19 pandemic.","volume":"202","author":"Panwar","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R3-20240807","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.CCM.0000104203.20830.AE","article-title":"Effects of cyclic opening and closing at low- and high-volume ventilation on bronchoalveolar lavage cytokines.","volume":"32","author":"Chu","year":"2004","journal-title":"Crit Care Med"},{"key":"R4-20240807","first-page":"CD004477","article-title":"Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.","volume":"2004","author":"Adhikari","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"R5-20240807","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12931-014-0128-8","article-title":"Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome.","volume":"15","author":"Dushianthan","year":"2014","journal-title":"Respir Res"},{"key":"R6-20240807","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/path.1440","article-title":"The clinical pathology of severe acute respiratory syndrome (SARS): A report from China.","volume":"200","author":"Ding","year":"2003","journal-title":"J Pathol"},{"key":"R7-20240807","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding.","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"R8-20240807","doi-asserted-by":"crossref","first-page":"2000607","DOI":"10.1183\/13993003.00607-2020","article-title":"Pathogenesis of COVID-19 from a cell biology perspective.","volume":"55","author":"Mason","year":"2020","journal-title":"Eur Respir J"},{"key":"R9-20240807","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1186\/s13054-020-03268-9","article-title":"Assessment of pulmonary surfactant in COVID-19 patients.","volume":"24","author":"Schousboe","year":"2020","journal-title":"Crit Care"},{"key":"R10-20240807","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer.","volume":"15","author":"Tian","year":"2020","journal-title":"J Thorac Oncol"},{"key":"R11-20240807","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome.","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R12-20240807","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in critically ill patients in the Seattle region - case series.","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N Engl J Med"},{"key":"R13-20240807","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1164\/rccm.202004-1471LE","article-title":"Lung mechanics in COVID-19 resemble respiratory distress syndrome, not acute respiratory distress syndrome: Could surfactant be a treatment?","volume":"202","author":"Koumbourlis","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R14-20240807","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1164\/rccm.202005-2025LE","article-title":"COVID-19 versus non-COVID-19-related acute respiratory distress syndrome: Differences and similarities.","volume":"202","author":"Brault","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-20240807","doi-asserted-by":"crossref","first-page":"1753466620951043","DOI":"10.1177\/1753466620951043","article-title":"Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia.","volume":"14","author":"Busani","year":"2020","journal-title":"Ther Adv Respir Dis"},{"key":"R16-20240807","doi-asserted-by":"crossref","first-page":"110020","DOI":"10.1016\/j.mehy.2020.110020","article-title":"Pulmonary surfactant itself must be a strong defender against SARS-CoV-2.","volume":"144","author":"Takano","year":"2020","journal-title":"Med Hypotheses"},{"key":"R17-20240807","first-page":"e53610","article-title":"Lavage-induced surfactant depletion in pigs as a model of the acute respiratory distress syndrome (ARDS).","volume":"115","author":"Russ","year":"2016","journal-title":"J Vis Exp"},{"key":"R18-20240807","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/thx.34.6.735","article-title":"Post-mortem lung volumes.","volume":"34","author":"Thurlbeck","year":"1979","journal-title":"Thorax"},{"key":"R19-20240807","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12871-020-01089-5","article-title":"Lung injury induced by short-term mechanical ventilation with hyperoxia and its mitigation by deferoxamine in rats.","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Anesthesiol"},{"key":"R20-20240807","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1165\/rcmb.2009-0210ST","article-title":"An official American Thoracic Society workshop report: Features and measurements of experimental acute lung injury in animals.","volume":"44","author":"Matute-Bello","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R21-20240807","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","article-title":"Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington state: A case series.","volume":"396","author":"Bradley","year":"2020","journal-title":"Lancet"},{"key":"R22-20240807","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ccc.2011.04.005","article-title":"Surfactant therapy for acute lung injury and acute respiratory distress syndrome.","volume":"27","author":"Raghavendran","year":"2011","journal-title":"Crit Care Clin"},{"key":"R23-20240807","first-page":"109s","article-title":"The adult respiratory distress syndrome: First trials with surfactant replacement.","volume":"3","author":"Richman","year":"1989","journal-title":"Eur Respir J Suppl"},{"key":"R24-20240807","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1378\/chest.09-0787","article-title":"Surfactant replacement therapy in ARDS.","volume":"136","author":"Spragg","year":"2009","journal-title":"Chest"},{"key":"R25-20240807","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.pcl.2008.02.016","article-title":"Surfactant for pediatric acute lung injury.","volume":"55","author":"Willson","year":"2008","journal-title":"Pediatr Clin North Am"},{"key":"R26-20240807","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1164\/rccm.201607-1401LE","article-title":"Did reduced alveolar delivery of surfactant contribute to negative results in adults with acute respiratory distress syndrome?","volume":"195","author":"Grotberg","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"R27-20240807","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1073\/pnas.1504025112","article-title":"Three-dimensional model of surfactant replacement therapy.","volume":"112","author":"Filoche","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R28-20240807","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4187\/respcare.02189","article-title":"AARC clinical practice guideline. Surfactant replacement therapy: 2013.","volume":"58","author":"Walsh","year":"2013","journal-title":"Respir Care"},{"key":"R29-20240807","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-018-0761-y","article-title":"Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: A meta-analysis of randomized controlled trials.","volume":"19","author":"Meng","year":"2019","journal-title":"BMC Pulm Med"},{"key":"R30-20240807","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1164\/rccm.200207-782OC","article-title":"Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant.","volume":"167","author":"Spragg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R31-20240807","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s001340050459","article-title":"Surfactant nebulisation prevents the adverse effects of surfactant therapy on blood pressure and cerebral blood flow in rabbits with severe respiratory failure.","volume":"23","author":"Dijk","year":"1997","journal-title":"Intensive Care Med"},{"key":"R32-20240807","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s001340050458","article-title":"Surfactant nebulisation: Lung function, surfactant distribution and pulmonary blood flow distribution in lung lavaged rabbits.","volume":"23","author":"Dijk","year":"1997","journal-title":"Intensive Care Med"},{"key":"R33-20240807","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s001340050358","article-title":"Surfactant nebulisation: Safety, efficiency and influence on surface lowering properties and biochemical composition.","volume":"23","author":"Dijk","year":"1997","journal-title":"Intensive Care Med"},{"key":"R34-20240807","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1136\/fn.78.1.F3","article-title":"Nebulisation of surfactants in an animal model of neonatal respiratory distress.","volume":"78","author":"Fok","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"R35-20240807","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1152\/jappl.1991.70.2.869","article-title":"Aerosolized surfactant treatment of preterm lambs.","volume":"70","author":"Lewis","year":"1991","journal-title":"J Appl Physiol (1985)"},{"key":"R36-20240807","doi-asserted-by":"crossref","first-page":"L32","DOI":"10.1152\/ajplung.00128.2017","article-title":"Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: A translational study.","volume":"314","author":"Spengler","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R37-20240807","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1164\/ajrccm.158.3.9801089","article-title":"Aerosolized surfactant improves pulmonary function in endotoxin-induced lung injury.","volume":"158","author":"Lutz","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R38-20240807","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJM199605303342201","article-title":"Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf acute respiratory distress syndrome sepsis study Group.","volume":"334","author":"Anzueto","year":"1996","journal-title":"N Engl J Med"},{"key":"R39-20240807","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00431-010-1292-6","article-title":"Aerosol delivery to ventilated newborn infants: Historical challenges and new directions.","volume":"170","author":"Mazela","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R40-20240807","doi-asserted-by":"crossref","first-page":"774","DOI":"10.4187\/respcare.03579","article-title":"Aerosolized surfactants, anti-inflammatory drugs, and analgesics.","volume":"60","author":"Willson","year":"2015","journal-title":"Respir Care"},{"key":"R41-20240807","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12931-019-1096-9","article-title":"From bench to bedside: In vitro and in vivo evaluation of a neonate-focused nebulized surfactant delivery strategy.","volume":"20","author":"Bianco","year":"2019","journal-title":"Respir Res"},{"key":"R42-20240807","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ppul.22844","article-title":"Aerosolized KL4 surfactant improves short-term survival and gas exchange in spontaneously breathing newborn pigs with hydrochloric acid-induced acute lung injury.","volume":"49","author":"Lampland","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"R43-20240807","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/17425247.2013.790362","article-title":"Aerosol delivery to intubated patients.","volume":"10","author":"Fink","year":"2013","journal-title":"Expert Opin Drug Deliv"},{"key":"R44-20240807","first-page":"845","article-title":"Influence of nebulizer type, position, and bias flow on aerosol drug delivery in simulated pediatric and adult lung models during mechanical ventilation.","volume":"55","author":"Ari","year":"2010","journal-title":"Respir Care"},{"key":"R45-20240807","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.rmed.2006.03.033","article-title":"Observational study to compare the clinical efficacy of the natural surfactants alveofact and curosurf in the treatment of respiratory distress syndrome in premature infants.","volume":"101","author":"Proquitt\u00e9","year":"2007","journal-title":"Respir Med"},{"key":"R46-20240807","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1164\/ajrccm.159.3.9806069","article-title":"Dosing and delivery of a recombinant surfactant in lung-injured adult sheep.","volume":"159","author":"Lewis","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R47-20240807","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.athoracsur.2011.06.107","article-title":"Large-animal models of acute respiratory distress syndrome.","volume":"93","author":"Ballard-Croft","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"R48-20240807","doi-asserted-by":"crossref","first-page":"S643","DOI":"10.33549\/physiolres.933539","article-title":"A novel experimental model of acute respiratory distress syndrome in pig.","volume":"65","author":"Ot\u00e1hal","year":"2016","journal-title":"Physiol Res"}],"container-title":["Critical Care Explorations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000338","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:12:53Z","timestamp":1723075973000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCE.0000000000000338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cce.0000000000000338","relation":{},"ISSN":["2639-8028"],"issn-type":[{"value":"2639-8028","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}